ACCF/AHA/CDC Conference Report on Emerging Infectious Diseases and Biological Terrorism Threats⁎⁎The findings and conclusions in this report are those of the Conference participants and do not necessarily reflect the official position of the American College of Cardiology Foundation, the American Heart Association, and the Centers for Disease Control and Prevention The Clinical and Public Health Implications for the Prevention and Control of Cardiovascular Diseases by Mensah, George A. et al.
*
o
D
T
A
C
c
A
G
i
i
C
Journal of the American College of Cardiology Vol. 49, No. 12, 2007
© 2007 by the American College of Cardiology Foundation and the American Heart Association, Inc. ISSN 0735-1097/07/$32.00
PACCF/AHA/CDC CONFERENCE REPORT
ACCF/AHA/CDC Conference Report on Emerging
Infectious Diseases and Biological Terrorism Threats*
The Clinical and Public Health Implications for the
Prevention and Control of Cardiovascular Diseases
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.01.017G
A
C
L
L
S
E
K
E
D
R
M
J
S
J
R
M
P
K
WWriting/
Steering
Committee
MembersR
R
J
J
E
M
C
M
R
ardiol 2007;49:1373–412.
This article has been copubeorge A. Mensah, MD, FACC, FAHA,
ugustus O. Grant, MB, CHB, PHD, FACC,
FAHA,
arl J. Pepine, MD, MACC, FAHA,
Conference Co-Chairs
arry M. Baddour, MD
eslie T. Cooper, JR, MD, FACC, FAHA
andra B. Dunbar, RN, DSN, FAAN, FAHA
rika S. Froelicher, RN, MA, MPH, PHD,
FAHA
urt J. Greenlund, PHD
dward L. Kaplan, MD, FAHA
obert A. Kloner, MD, PHD, FACC, FAHA
Z
G
R
S
J
C
R
D
†
lished in the March 27, 2007, issue of Circulation.
Request Formarwin R. Labarthe, MD, MPH, PHD, FAHA
ussell V. Luepker, MD, MS, FACC, FAHA
ohammad Madjid, MD
ames E. Muller, MD, FACC, FAHA
iobhán O’Connor, MD, MPH
oseph P. Ornato, MD, FACC, FACP,
FACEP, FAHA
ose Marie Robertson, MD, FACC, FAHA
ichael J. Roy, MD, MPH, FACP
rediman K. Shah, MD, FACC
athryn A. Taubert, PHD, FAHA
alter R. Wilson, MDhi-Jie Zheng, MD, PHDACCF
Task
Force
on Clinical
Expert
Consensus
Documentsobert A. Harrington, MD, FACC, Chair
onathan Abrams, MD, FACC‡
effrey L. Anderson, MD, FACC
ric R. Bates, MD, FACC
ark J. Eisenberg, MD, MPH, FACC
indy L. Grines, MD, FACC
ark A. Hlatky, MD, FACC
obert C. Lichtenberg, MD, FACCerald M. Pohost, MD, FACC, FAHA
ichard S. Schofield, MD, FACC
amuel J. Shubrooks, JR, MD, FACC
ames H. Stein, MD, FACC
ynthia M. Tracy, MD, FACC
obert A. Vogel, MD, FACC†
eborah J. Wesley, RN, BSN
Immediate Past Chair; ‡Former Task Force Member duringJonathan R. Lindner, MD, FACC writing effort
The findings and conclusions in this report are those of the Conference participants and do not necessarily reflect the
fficial position of the American College of Cardiology Foundation, the American Heart Association, and the Centers for
isease Control and Prevention
his document was approved by the American Heart Association Scientific
dvisory Coordinating Committee in February 2007. The American College of
ardiology Foundation Board of Trustees does not require approval of consensus
onference reports. See formal policy stated above.
When citing this document, the American College of Cardiology and the
merican Heart Association would appreciate the following citation format: Mensah
A, Grant AO, Pepine CJ, et al. ACCF/AHA/CDC conference report on emerging
nfectious diseases and biological terrorism threats: the clinical and public health
mplications for the prevention and control of cardiovascular diseases. J Am Coll
This document is available on the World Wide Web sites of the Ameri-
can College of Cardiology (www.acc.org), the American Heart Associa-
tion (www.americanheart.org), and the Centers for Disease Control and Prevention
(www.cdc.gov/mmwr/). For copies of this document, please contact Elsevier Inc.
Reprint Department, fax (212) 633-3820, e-mail reprints@elsevier.com.
Permissions: Modification, alteration, enhancement and/or distribution of this
document are not permitted without the express permission of the American Heart
Association. Instructions for obtaining permission are located at http://
www.americanheart.org/presenter.jhtml?identifier_4431. A link to the “Permission” appears on the right side of the page.
LJ
L
H
S
E
A
K
E
R
1374 Mensah et al. JACC Vol. 49, No. 12, 2007
ACCF/AHA/CDC Conference Report March 27, 2007:1373–5Participants/Authors
B
D
R
M
G
*
S
J
C
E
R
M
R
P
G
K
W
†
*
MARRY M. BADDOUR, MD
Infectious Disease Society of America Representative
Professor of Medicine
Mayo Clinic College of Medicine
200 First Street SW
Rochester, MN 55905
EAN CHABUT, BSN, MPH
Deputy Director, Public Health Administration
Michigan Department of Community Health
Capitol View Building
201 Townsend
Lansing, MI 48913
ESLIE T. COOPER, JR, MD, FACC, FAHA
Professor of Medicine
Mayo Clinic College of Medicine
Consultant, Cardiovascular Diseases
Mayo Clinic
200 First Street SW
Rochester, MN 55906
AROLD COX
Chief Public Health Officer
Cambridge Department of Health
119 Windsor Street
Cambridge, MA 02139
ANDRA B. DUNBAR, RN, DSN, FAAN,
FAHA
American Nurses Association Representative
Emory University
School of Nursing
1520 Clifton Road
Atlanta, GA 30322
RIKA S. FROELICHER, RN, MA, MPH,
PHD, FAHA
Professor, Department of Physiological Nursing
Department of Epidemiology & Biostatistics
UCSF School of Nursing & Medicine
2 Koret Way, Room N631K
San Francisco, CA 94143-0610
UGUSTUS O. GRANT, MB, CHB, PHD,
FACC, FAHA
Duke University Medical Center
Box 3504
Durham, NC 27702-3504
URT J. GREENLUND, PHD
Division for Heart Disease and Stroke Prevention
Centers for Disease Control and Prevention
4770 Buford Hwy. NE, Mailstop K-47
Atlanta, GA 30341-3717
DWARD L. KAPLAN, MD, FAHA
American Academy of Pediatrics Representative
Infectious Disease Society of America Representative
University of Minnesota Medical School
SE MMC 296
420 Delaware Street SE
Minneapolis, MN 55455-0374
OBERT A. KLONER, MD, PHD, FACC,
FAHA
Professor of Medicine
Keck School of Medicine at the University ofSouthern CaliforniaDirector of Research, Heart Institute
Good Samaritan Hospital
Heart Institute
1225 Wilshire Boulevard
Los Angeles, CA 90017-2395
. WAINE KONG, PHD, JD
Association of Black Cardiologists Representative
Chief Executive Officer
Association of Black Cardiologists, Inc.
5355 Hunter Road
Atlanta, GA 30349
ARWIN R. LABARTHE, MD, MPH, PHD,
FAHA
Director, Division for Heart Disease and Stroke
Prevention
National Center for Chronic Disease Prevention
and Health Promotion
CDC and Prevention
4770 Buford Highway NE, Mailstop K-47
Atlanta, GA 30341-3717
USSELL V. LUEPKER, MD, MS, FACC,
FAHA
American College of Physicians Representative
University of Minnesota
Div of Epidemiology, Dept of Medicine
1300 S Second St., Suite 300
Minneapolis, MN 55454-1087
OHAMMAD MADJID, MD
University of Texas Health Science Center at
Houston and Texas Heart Institute
6770 Bertner Avenue, MC2-255
Houston, TX 77030
EORGE A. MENSAH, MD, FACC, FAHA
Chief Medical Officer
National Center for Chronic Disease
Prevention and Health Promotion
Centers for Disease Control and Prevention
Atlanta, GA 30341-3717
JAMES E. MULLER, MD, FACC, FAHA
Director, Clinical Research, Cardiology Division
MGH and Harvard Medical School
CIMIT
400 Charles River Plaza, Suite 400
Boston, MA 02114
IOBHÁN O’CONNOR, MD, MPH
Coordinating Center for Infectious Diseases
Centers for Disease Control and Prevention
1600 Clifton Road, NE Mail Stop G-37
Atlanta, GA 30333
OSEPH P. ORNATO, MD, FACC, FACP,
FACEP, FAHA
American College of Emergency Physicians
Representative
Professor and Chair
Department of Emergency Medicine
VA Commonwealth Univ Health System
P.O. Box 980525 401 N
12th Street, Room G-248
Richmond, VA 29298-0525
H
HARL J. PEPINE, MD, MACC, FAHA
Professor and Chief, Division of Cardiovascular
Medicine
University of Florida College of Medicine
6308 SW 37th Way
Gainesville, FL 32608-5105
LIZABETH M. PUCKETT
Division of Public Health/DHHS
1915 Mail Service Center
Raleigh, NC 27699-1915
OSE MARIE ROBERTSON, MD, FACC,
FAHA
Chief Science Officer
American Heart Association
7272 Greenville Avenue
Dallas, TX 75231-5123
ICHAEL J. ROY, MD, MPH, FACP
American Medical Association Representative
Director, Division of Military Internal Medicine
Uniformed Services University of the Health Science
Department of Medicine
Bethesda, MD 20814
AMONA DAWN SCHAEFFER
Director, Chronic Disease Prevention Program
109 Governor Street, 10th Floor
Richmond, VA 23219
REDIMAN K. SHAH, MD, FACC
Director, Division of Cardiology
Cedars-Sinai Medical Center
Division of Cardiology
8700 Beverly Boulevard, Room 5531
Los Angeles, CA 90048-1804
EORGE SOPKO, MD
National Heart, Lung, and Blood Institutes
Representative
National Institutes of Health
6701 Rockledge Drive
Bethesda, MD 20817-1813
ATHRYN A. TAUBERT, PHD, FAHA
Senior Scientist
American Heart Association
7272 Greenville Avenue
Dallas, TX 75231-5123
ALTER R. WILSON, MD
Infectious Disease Society of America Representative
American College of Physicians Representative
Mayo Clinic
200 First Street SW
Rochester, MN 55905
ZHI-JIE ZHENG, MD, PHD
Lead Epidemiologist
Division for Heart Disease and Stroke
Prevention
Centers for Disease Control and Prevention
Atlanta, GA 30341-3717
Dr. Muller is now CEO, InfraReDx Inc., Burlington,
A 01803. †Dr. Zheng is now with the National
eart, Lung, and Blood Institute, National Institutes of
ealth, Bethesda, MD 20824.
A
B
D
M
D
M
M
D
D
D
D
D
D
D
D
D
D
D
D
D
M
D
D
D
M
D
D
D
D
D
T
*
1375JACC Vol. 49, No. 12, 2007 Mensah et al.
March 27, 2007:1373–5 ACCF/AHA/CDC Conference ReportStaff
AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION
John C. Lewin, MD, Chief Executive Officer
Thomas E. Arend, Jr, Esq., Chief Operating Officer
Lisa Bradfield, Associate Director, Clinical Policy and Documents
Erin A. Barrett, Specialist, Clinical Policy and Documents
Peg Christiansen, Librarian
AMERICAN HEART ASSOCIATION
M. Cass Wheeler, Chief Executive Officer
Rose Marie Robertson, MD, FACC, FAHA, Chief Science Officer
Kathryn A. Taubert, PhD, FAHA, Senior Science AdvisorPPENDIX 1. ACCF/AHA/CDC CONSENSUS CONFERENCE REPORT ON EMERGING INFECTIOUS DISEASES AND
IOLOGICAL TERRORISM THREATS—PARTICIPANTS’ RELATIONSHIPS WITH INDUSTRY
Name
Consulting Fees/
Honoraria Speaker’s Bureau
Ownership/
Partnership/
Principal Research Grants
Institutional or Other
Financial Benefit
Expert Witness
or Consultant
r. Larry M. Baddour None None None None ● Mayo Clinic None
s. Jean Chabut None None None None None None
r. Leslie T. Cooper, Jr. ● Acambis* None None None None None
r. Harold Cox None None None None None None
s. Sandra B. Dunbar None None None None None None
r. Erika S. Froelicher None None None None None None
r. Augustus O. Grant None None None None None None
r. Kurt J. Greenlund None None None None None None
r. Edward L. Kaplan None None None None None None
r. Robert A. Kloner ● Pfizer Inc.† ● Pfizer Inc.† None None None None
r. B. Waine Kong None None None None None None
r. Darwin R. Labarthe None None None None None None
r. Russell V. Luepker None None None None None None
r. Mohammad Madjid ● Hoffman-LaRoche
Inc.*
None None ● Hoffman-LaRoche
Inc.*
● Pfizer Inc.†
None None
r. George A. Mensah None None None None None None
r. James E. Muller None None ● InfraReDx
Inc.
None None None
r. Siobhán O’Connor None None None None None None
r. Joseph P. Ornato None None None None None None
s. Elizabeth M. Puckett None None None None None None
r. Carl J. Pepine None None None None None None
r. Rose Marie Robertson None ● Merck Science
Advisory
Board‡
None None None None
r. Michael J. Roy None None None None None None
s. Ramona Dawn Schaeffer None None None None None None
r. Prediman K. Shah None None None None None None
r. George Sopko None None None None None None
r. Kathryn A. Taubert None None None None None None
r. Walter R. Wilson None None None None None None
r. Zhi-Jie Zheng None None None None None None
his table represents the relationships of members with industry that were reported in writing at the consensus conference. It does not necessarily reflect relationships with industry at the time of publication.
Indicates modest-level relationship ($10,000 or less); †indicates significant-level relationship (more than $10,000); ‡indicates spousal relationship.
